Morphine sulfate concentration

Severe chronic pain associated with terminal cancer- Prior to initiation of the morphine infusion (in concentrations between 0.2 to 1 mg/mL), a loading dose of 15 mg or more of morphine sulfate may be administered by IV push to alleviate pain. 

OFFICIAL NAMES Morphine sulfate or morphine hydrochloride (solutions for injection), Duramorph (for spinal use), MS Contin and Oramorph SR (long-acting, controlled release oral form), Kadian (oral, sustained release), MSIR (instant release), Roxanol (liquid concentrate)... 

Fig. 5-30. Separation of epinephrine, ephedrine, and opium alkaloids. - Separator column IonPac NS1 (10 pm) eluent 0.005 mol/L sodium octanesulfonate + 0.05 mol/L KH2P04 (pH 4.0) / acetonitrile (89 11 v/v) flow rate 1 mL/min detection UV (220 nm) injection volume 50 pL solute concentrations 10 mg/L epinephrine, 10 mg/L morphine sulfate, 20 mg/L ephedrine hydrochloride, and 20 mg/L codeine phosphate.

A. Parenteral. Morphine sulfate for injection variety of available concentrations from 0.5 to 50 mg/mL. 

Trade/Proprietary Names oral - Morphine Sulfate Immediate Release Tablets , Morphine Sulfate Oral Solution , OMS Concentrate, Roxa-nol Concentrated Oral Solution, Oramorph parenteral - Min-I-Jet-Morphine Sulfate Injection , Morphine Sulfate Add-Vantage , Select-A-Jet Morphine Sulfate Injection , Infumorph ... 

Ease of use, tolerability controlled-release oral formulations of morphine sulfate provide significant pain relief, ensure uniform blood concentrations, offer less frequent dosing, fewer adverse side effects, and flexible titration with different dosing strengths. 

Because fluoroquinolones have a wide therapeutic index and dose-dependent toxicity, routine drug monitoring is not indicated. Monitoring fluoroquinolone concentration is indicated in renal failure, which wfll cause fluoroquinolones to accumulate. Optimal response occurs when serum concentration exceeds 1.5 Llg/mL. Activity is maintained as long as the trough concentration is >0.2flg/mL. Coadministration with antacids, ferrous sulfate, food, or sucralfate reduces absorption by 30% to 60%. Co-administration with morphine reduces absorption by >50%. 

Raman spectra of drugs are fuU of information and are unique to each substance. Very similar chemicals, e. g. amphetamine x HCl and amphetamine sulfate or heroin and morphine, yield very different spectra. Usually such samples consist of many constituents, hence multivariate analysis (cf. Chapter 13) should be used to obtain quantitative models of drug concentrations in solid mixtures. The abihty to correctly identify unknowns also depends upon the availabihty of high-quahty reference spectra. 

---